🇺🇸 FDA

Intelligence · Patent portfolio

Paxlovid Patents

Full USPTO pharma patent portfolio for Paxlovid — grant dates, expiration, and drug cross-links.

Patents
193
Expiring ≤24m
2

Quick answer

Paxlovid has 193 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 5

  1. US 9707315

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9707252

    Synthetic sealants

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9687450

    Oxidized cellulose microspheres

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9682069

    Methods of treating Dravet syndrome

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9676823

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9655842

    Injectable non-aqueous compositions and methods of treating vascular disease

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9650256

    Cerium oxide-aluminosilicate tubes nanocomposite and method of preparation

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9642946

    Medical device with intrapore films

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9610261

    Methods of treating Prader-Willi Syndrome

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9603781

    Skin cleaning kit

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9592221

    Antibacterial agents: aryl myxopyronin derivatives

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9555037

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9555016

    Lytic agents for use in treating intravascular clots

    Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9522963

    Dissolution of oxidized cellulose

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9517067

    System and method for satellite drug delivery

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9511175

    Medical devices with an activated coating

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9480770

    Methods for preparation of medical dressing containing antimicrobial agent

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9468684

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9446028

    Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndrome

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9433658

    Medical electrode

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9421169

    Oral dosage forms for delivery of therapeutic agents

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9399133

    Non-invasive automated electrical control systems and methods for monitoring animal conditions

    Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9399034

    Methods of sedation during critical care treatment

    Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9351968

    Methods of treating developmental disorders using pipradrol

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9339495

    Methods of increasing tonic inhibition and treating secondary insomnia

    Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9320592

    Coated medical devices and methods of making and using same

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9315495

    Antibacterial agents: aryl myxopyronin derivatives

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9296776

    Substituted nucleoside derivatives with antiviral and antimicrobial properties

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9271937

    Oxidized cellulose microspheres

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9273191

    Medical devices with an activated coating

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9271985

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9265828

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9226955

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9216240

    Differential loading of drug-eluting medical devices

    Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9200057

    Methods and compositions for inducing an immune response to EGFRvIII

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9168227

    Multi-encapsulated microspheres made with oxidized cellulose for in-situ reactions

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9144611

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9144634

    Medical device with intrapore films

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9138489

    Oxidized cellulose miczrospheres including visualization agents

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9012467

    Compositions for intratumoral administration

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8980302

    Therapeutic implant

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8974776

    Biodegradable peptide releasing polymers

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8968785

    Surgical compositions

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8968234

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8968783

    Hydrogel implants with varying degrees of crosslinking

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8945108

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8920867

    Methods of forming self-supporting films for delivery of therapeutic agents

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8900616

    System and method for satellite drug delivery

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Paxlovid have?

193 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Paxlovid patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.